These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[ ]
|
Preliminary Proxy Statement
|
|
[ ]
|
Confidential, For Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
[X]
|
Definitive Proxy Statement
|
|
[ ]
|
Definitive Additional Materials
|
|
[ ]
|
Soliciting Material Pursuant to §240.14a-12
|
|
[X]
|
No
fee required.
|
|
|
[ ]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
|
|
(1)
|
Title of each class of securities to which transaction
applies:
|
|
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction
applies:
|
|
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was
determined):
|
|
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
|
|
[ ]
|
Fee
paid previously with preliminary materials.
|
|
|
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
|
|
|
(4)
|
Date Filed:
|
|
|
YOUR VOTE IS IMPORTANT
All stockholders are cordially invited to attend the Annual Meeting
in person. However, to ensure your representation at the Annual
Meeting, you are urged to vote online or complete, sign, date and
return, in the enclosed postage paid envelope, the enclosed proxy
card as soon as possible. Returning your proxy will help us assure
that a quorum will be present at the Annual Meeting and avoid the
additional expense of duplicate proxy solicitations. Any
stockholder attending the Meeting may vote in person, even if he or
she has returned a proxy.
|
|
|
|
|
|
|
By Order of the Board of Directors,
|
|
|
|
|
|
|
|
|
|
|
|
Guy Dubois
|
|
|
Chief Executive Officer and Chairman of the Board of
Directors
|
|
Name
|
|
Served as
Director Since
|
|
Age
|
|
Principal Business Experience
|
|
|
|
|
|
|
|
|
|
Guy Dubois
|
|
2012
|
|
58
|
|
Guy Dubois has served as our Chairman since February 2013, and
became a director in December 2012. Mr. Dubois also served as a
member of the Company’s Executive Committee from October 2012
to September 2016, and was appointed to serve as Chief Executive
Officer of the Company in September 2016. Mr. Dubois is a director
of Singapore-based Tetra House Pte. Ltd., a provider of consulting
and advisory services worldwide; and a director of RNTS Media NV, a
Luxembourg listed digital content developer and mobile application
advertising monetization platform provider. Mr. Dubois is a former
director and CEO of Gategroup AG, and held various executive
leadership roles at Gate Gourmet Holding LLC. Mr. Dubois has held
executive management positions at Roche Vitamins Inc. in New
Jersey, as well as regional management roles in that firm’s
Asia Pacific operations. Mr. Dubois also served the European
Organization for Nuclear Research (CERN) team in Switzerland in
various roles, including treasurer and chief accountant. Mr. Dubois
also worked with IBM in Sweden as Product Support Specialist for
Financial Applications. A Belgian citizen, Mr. Dubois holds a
degree in financial science and accountancy from the Limburg
Business School in Diepenbeek, Belgium.
In considering Mr. Dubois as a director of the Company, the current
Board of Directors reviewed his extensive financial and management
expertise and experience. In addition, Mr. Dubois’ public
company senior management and board experience, and the leadership
he has shown in his positions with prior companies, were considered
important factors in the determination of the current Board of
Directors.
|
|
|
|
|
|
|
|
|
|
David S. Boone
|
|
2011
|
|
56
|
|
David S. Boone became a director of the Company on December 21,
2011. Mr. Boone currently serves as the CEO of Alacura and Angel
MedFlight, a private equity backed medical transportation company.
He has served in executive roles with a variety of publicly traded
and start-up organizations including Kraft General Foods, Sears,
PepsiCo, Safeway and Belo Corporation, as well as serving as the
CFO of Intira Corporation and CEO of Paranet Solutions, LLC. In
addition, he has served as a consultant with the Boston Consulting
Group. Mr. Boone was CEO, President and Director of American
CareSource Holdings from 2005 to 2011, a NASDAQ traded company. He
was the 2009 Ernst and Young Entrepreneur of the Year winner for
Health Care in the Southwest Region. Mr. Boone serves on a number
of private company boards and serves on the board of the Texas
Kidney Foundation. Mr. Boone graduated from the University of
Illinois, cum laude, in 1983 majoring in accounting. Mr. Boone is a
Certified Public Accountant. He received his master’s degree
in business administration from Harvard Business School in
1989.
In considering Mr. Boone as a director of the Company, the current
Board of Directors reviewed his extensive financial expertise and
experience. In addition, Mr. Boone's public company senior
management and board experience, and the leadership he has shown in
his positions with prior companies and as a director of the
Company, were considered important factors in the determination of
the current Board of Directors.
|
|
Name
|
|
Served as
Director Since
|
|
Age
|
|
Principal Business Experience
|
|
|
|
|
|
|
|
|
|
Dirk Karel J. van Daele
|
|
2015
|
|
55
|
|
Mr. van Daele, a resident of Switzerland, became a director of the
Company in May 2015 and is currently a principal of Anoa Capital
SA, a Luxembourg investment advisory company focused on advisory
services for direct lending and acquisition of secondary loan
portfolios. Mr. van Daele has served in that capacity since January
2010. Prior to joining Anoa Capital SA, Mr. van Daele was the
Managing Director and Head of Global Finance, Asia Pacific
(Singapore) for Union Bank of Switzerland, having served in that
capacity since July 1998. He received his Master of Arts in
Economics at the University of Louvain (Belgium) in
1984.
In considering Mr. van Daele’s nomination, the Board of
Directors believed his extensive international finance, banking and
senior management experience would assist in the Board’s
deliberations as the Company expands operations internationally and
finances its growth.
|
|
|
|
|
|
|
|
|
| Karen Macleod |
|
2016
|
|
53
|
|
Ms.
Macleod
became a director of the Company in
January 2016 and
currently serves as CEO
of Arete Group LLC, a professional services firm. Prior to Arete
Group, Ms. Macleod was President of Tatum LLC, a New York-based
professional services firm owned by Randstad, from 2011-2014, and
was a co-founder of Resources Connection (NASDAQ:RECN), now known
as RGP, a multinational professional services firm founded as a
division of Deloitte in June 1996. Ms. Macleod served in several
positions for RGP, including as a director from 1999- 2009 and
President, North America from 2004-2009. Prior to RGP, Ms. Macleod
held several positions in the audit department of Deloitte between
1985-1994. Ms. Macleod currently serves as a director for A-Connect
(Schweiz) AG, a privately held, Swiss-based global
professional services firm and was a director for Overland
Solutions from 2006-2013. Ms. Macleod holds a Bachelor of
Science in Business/Managerial Economics from the University of
California, Santa Barbara.
In considering Ms. Macleod’s nomination, the Board of
Directors believes Ms. Macleod’s senior public company
leadership experience along with her finance and accounting
background are important to the ongoing growth of the Company and
corporate governance excellence
.
|
|
|
|
|
|
|
|
|
|
Eric Rosenblum
|
|
2016
|
|
47
|
|
Mr.
Rosenblum
became a director of the Company in September 2016 and is currently
a senior executive with Palantir Technologies (a privately held big
data analytics company), where he oversees several product groups.
In his role, he has overseen the deployment of data analytics
platforms for both government and large commercial institutions.
From 2012 to 2014, Mr. Rosenblum served as a Vice President and
Chief Operating Officer at drawbridge, Inc. a mobile advertising
start-up, during which time Drawbridge developed a cross-device
digital marketing technology based on algorithms without the use of
personally identifiable information. Mr. Rosenblum served as a
Director of Product, and Director of Strategy and Business
operations at Google, Inc. from 2008 to 2012. From 2005 to 2008 he
served as a Managing Director, China and General Manager, Strategy
for Realnetworks, Inc. Mr. Rosenblum earned his Bachelor’s
degree in East Asian Studies and Economics at Harvard University
and his Masters of Business Administration from the Massachusetts
Institute of Technology.
In considering Mr. Rosenblum’s nomination, the Board of
Directors believed his extensive technological and analytics
background, international business and management experience would
assist in the Board’s deliberations regarding product
development and international growth.
|
|
|
|
|
|
|
|
|
|
Dr. Ray Johnson
|
|
2016
|
|
61
|
|
Dr. Johnson became a director of the Company in September 2016 and
currently serves as an Executive in Residence with Bessemer Venture
Partners. From 2006 through February 2015, Dr. Johnson served as
the Senior Vice President and Chief Technology Officer of the
Lockheed Martin Corporation, where he led the strategic areas of
technology, engineering, production operations, global supply
chain, program management, and logistics and sustainment. Prior to
his time with Lockheed Martin, Dr. Johnson served as the Chief
Operating Officer for Modern Technology Solutions, Inc. of
Alexandria, Virginia from 2005 to 2006, and from 1996 to 2005, he
served in a number of executive positions with Science Applications
International Corporation, including Senior Vice President and
General Manager of the Advanced Concepts Business Unit. Dr. Johnson
served for 12 years as an officer in the U.S. Air Force. Currently
Dr. Johnson serves as a director on the boards of: QxBranch, LLC,
Terrestrial Energy, Inc., United Sciences, LLC, and 8 Rivers
Capital, LLC, all privately held companies. He received his
Bachelor’s degree in Electrical Engineering from Oklahoma
State University, and his Master’s and Ph.D. degrees in
Electrical Engineering from the Air Force Institute of
Technology.
In considering Dr. Johnson’s nomination, the Board of
Directors reviewed his extensive technology expertise and
experience. In addition, Dr. Johnson's public company senior
management and board experience, and the leadership he has shown in
his positions with prior companies, were considered important
factors in the determination of the current Board of
Directors.
|
|
Name
|
|
Age
|
|
Position
|
|
Guy Dubois
|
|
58
|
|
Chief Executive Officer
|
|
Peter K. Poli
|
|
55
|
|
Chief Financial Officer
|
|
Derek Cassell
|
|
43
|
|
President
|
|
Name and
|
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
All Other Compensation
|
Total
|
|
Principal Position
|
Year
|
($)
|
($)
|
($)
|
($)
|
($)
|
($)
|
|
|
|
|
|
|
|
|
|
|
Guy
Dubois
|
2016
|
$
-
|
$
-
|
$
30,000
|
$
170,182
|
$
-
|
$
200,182
|
|
Chairman and Chief Executive Officer
|
2015
|
$
-
|
$
-
|
$
-
|
$
419,445
|
$
-
|
$
419,455
|
|
|
|
|
|
|
|
|
|
|
Peter Poli
(1)
|
2016
|
$
-
|
$
-
|
$
-
|
$
-
|
$
-
|
$
-
|
|
Chief Financial Officer
|
2015
|
$
-
|
$
-
|
$
-
|
$
-
|
$
-
|
$
-
|
|
|
|
|
|
|
|
|
|
|
Derek Cassell
(2)
|
2016
|
$
206,076
|
$
-
|
$
42,500
|
$
-
|
$
-
|
$
248,576
|
|
President
|
2015
|
$
190,000
|
$
-
|
$
42,500
|
$
-
|
$
-
|
$
232,500
|
|
|
|
|
|
|
|
|
|
|
John R. Merrill
(3)
|
2016
|
$
153,854
|
$
-
|
$
42,500
|
$
-
|
$
-
|
$
196,354
|
|
Former Chief Financial Officer
|
2015
|
$
180,000
|
$
-
|
$
42,500
|
$
-
|
$
74,700
|
$
297,200
|
|
|
|
|
|
|
|
|
|
|
Mark Attarian
(4)
|
2016
|
$
91,167
|
$
-
|
$
-
|
$
-
|
$
-
|
$
91,167
|
|
Former Chief Financial Officer
|
2015
|
$
-
|
$
-
|
$
-
|
$
-
|
$
-
|
$
-
|
|
(1)
|
Mr. Poli began serving as our Chief Financial Officer on January 6,
2017 and, as such, did not receive any compensation from the
Company during either fiscal 2016 or 2015.
|
|
(2)
|
Mr. Cassell was appointed President of the Company on December 19,
2016. Prior to this appointment, Mr. Cassell served as the
Company’s President of the Company’s America’s
Division since June 2014.
|
|
(3)
|
Mr. Merrill’s employment as the Company’s Chief
Financial Officer was terminated on September 27,
2016.
|
|
(4)
|
Mr. Attarian was appointed to serve as the Company’s Chief
Financial Officer on September 12, 2016, and previously served as
the Company’s Chief Administrative Officer since July 11,
2016. Mr. Attarian subsequently resigned from the Company on
November 15, 2016.
|
|
Name
(1)
|
Number of securities underlying unexercised options (#)
exercisable
|
Number of securities underlying unexercised options (#)
exercisable
|
Equity incentive plan awards: Number of underlying unexercised
unearned options (#)
|
Option
exercise
price ($)
|
Option
expiration
date
|
Number of shares or units of stock that have not vested
(#)
|
Market value of shares or units of stock that have not vested
($)
|
Equity incentive plan awards: Number of Unearned shares, units or
other rights that have not vested (#)
|
Equity incentive plan awards: Market or Payout value of unearned
shares, units or other rights that have not vested ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
Guy
Dubois
|
2,385
|
-
|
-
|
$
12.580
|
3/21/2017
|
-
|
-
|
-
|
-
|
|
|
64,665
|
-
|
-
|
$
9.000
|
4/15/2017
|
-
|
-
|
-
|
-
|
|
|
4,083
|
-
|
-
|
$
14.700
|
6/30/2017
|
-
|
-
|
-
|
-
|
|
|
2,280
|
-
|
-
|
$
19.460
|
9/30/2017
|
-
|
-
|
-
|
-
|
|
|
2,432
|
-
|
-
|
$
18.750
|
3/31/2018
|
-
|
-
|
-
|
-
|
|
|
51,576
|
-
|
-
|
$
17.450
|
6/2/2018
|
-
|
-
|
-
|
-
|
|
|
2,647
|
-
|
-
|
$
15.450
|
6/30/2018
|
-
|
-
|
-
|
-
|
|
|
14,988
|
-
|
-
|
$
12.01
|
1/27/2017
|
-
|
-
|
-
|
-
|
|
|
8,868
|
-
|
-
|
$
10.15
|
4/20/2017
|
-
|
-
|
-
|
-
|
|
|
113,310
|
-
|
-
|
$
9.65
|
8/14/2017
|
-
|
-
|
-
|
-
|
|
|
8,571
|
-
|
-
|
$
10.50
|
9/30/2017
|
-
|
-
|
-
|
-
|
|
|
12,676
|
-
|
-
|
$
7.10
|
10/14/2017
|
-
|
-
|
-
|
-
|
|
|
15,126
|
-
|
-
|
$
5.95
|
1/15/2018
|
-
|
-
|
-
|
-
|
|
|
14,286
|
-
|
-
|
$
6.30
|
3/31/2018
|
-
|
-
|
-
|
-
|
|
|
18,000
|
-
|
-
|
$
5.00
|
6/30/2018
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
John
R. Merrill
|
-
|
-
|
-
|
$
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark
Attarian
|
-
|
125,000
|
-
|
$
(2
)
|
09/11/2019
|
-
|
-
|
-
|
-
|
|
|
Fees earned
|
Stock awards
|
Option awards
|
Total
|
|
Name**
|
($)*
|
($)
|
($)
|
($)
|
|
|
|
|
|
|
|
David
Boone
|
$
-
|
$
59,997
|
$
178,107
|
$
238,104
|
|
Karen
Macleod
|
$
-
|
$
15,000
|
$
66,730
|
$
81,730
|
|
Dirk
van Daele
|
$
-
|
$
22,171
|
$
128,310
|
$
150,481
|
|
|
Grant
|
|
Expiration
|
|
Exercise
|
|
Number of
|
|
Compensation
|
|||
|
Name
|
Date
|
|
Date
|
|
Price
|
|
Options
|
|
Expense
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
David S. Boone
|
3/22/13
|
|
3/21/17
|
|
$
|
12.58
|
|
|
8,943
|
|
$
|
43,809
|
|
|
7/1/13
|
|
6/30/17
|
|
$
|
14.70
|
|
|
4,083
|
|
$
|
23,640
|
|
|
10/1/13
|
|
9/30/17
|
|
$
|
19.46
|
|
|
2,280
|
|
$
|
17,982
|
|
|
1/2/14
|
|
12/31/18
|
|
$
|
19.29
|
|
|
2,344
|
|
$
|
12,014
|
|
|
10/15/15
|
|
10/14/17
|
|
$
|
7.10
|
|
|
12,676
|
|
$
|
24,571
|
|
|
1/15/16
|
|
1/15/18
|
|
$
|
5.95
|
|
|
15,126
|
|
$
|
45,008
|
|
|
7/1/16
|
|
6/30/18
|
|
$
|
5.00
|
|
|
18,000
|
|
$
|
53,460
|
|
|
9/30/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
12,500
|
|
$
|
30,000
|
|
|
10/1/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
5,882
|
|
$
|
25,000
|
|
|
12/30/16
|
|
12/30/18
|
|
$
|
4.50
|
|
|
9,191
|
|
$
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Karen Macleod
|
7/1/16
|
|
6/30/18
|
|
$
|
5.00
|
|
|
9,000
|
|
$
|
26,730
|
|
|
9/30/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
6,250
|
|
$
|
15,000
|
|
|
10/1/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
5,882
|
|
$
|
25,000
|
|
|
12/30/16
|
|
12/30/18
|
|
$
|
4.50
|
|
|
9,191
|
|
$ |
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dirk van Daele
|
10/15/15
|
|
10/14/17
|
|
$
|
7.10
|
|
|
6,338
|
|
$
|
16,504
|
|
|
1/15/16
|
|
1/15/18
|
|
$
|
5.95
|
|
|
7,563
|
|
$
|
22,504
|
|
|
7/1/16
|
|
6/30/18
|
|
$
|
5.00
|
|
|
9,000
|
|
$
|
26,730
|
|
|
9/30/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
6,250
|
|
$
|
15,000
|
|
|
10/1/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
5,882
|
|
$
|
25,000
|
|
|
12/30/16
|
|
12/30/18
|
|
$
|
4.50
|
|
|
9,191
|
|
$
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Ray Johnson
|
10/1/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
5,882
|
|
$
|
25,000
|
|
|
12/30/16
|
|
12/30/18
|
|
$
|
4.50
|
|
|
9,191
|
|
$
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eric Rosenblum
|
10/1/16
|
|
9/30/18
|
|
$
|
7.20
|
|
|
5,882
|
|
$
|
25,000
|
|
|
12/30/16
|
|
12/30/18
|
|
$
|
4.50
|
|
|
9,191
|
|
$
|
25,000
|
|
Name and Address of
|
Common Stock
|
|
|
Beneficial Owner (1)
|
Shares
|
%
|
|
|
|
|
|
5% Beneficial Owners:
|
|
|
|
Sapinda
Asia Limited (2)
|
5,172,214
|
50.05
%
|
|
Safety
Invest S.A., Compartment Secure I (3)
|
1,890,697
|
18.30
%
|
|
|
|
|
|
Directors and Named Executive Officers:
|
|
|
|
Guy
Dubois (4)
|
351,432
|
3.29
%
|
|
Peter
Poli
|
-
|
*
|
|
Derek
Cassell
|
5,195
|
*
|
|
David
S. Boone (5)
|
110,289
|
*
|
|
Karen
Macleod (6)
|
32,704
|
*
|
|
Dirk
van Daele (7)
|
106,123
|
*
|
|
Dr.
Ray Johnson (8)
|
15,073
|
*
|
|
Eric
Rosenblum (9)
|
15,073
|
*
|
|
All
directors and executive officers as a group
(7
persons)
|
635,889
|
5.85
%
|
|
(1)
|
Except as otherwise indicated, the business address for these
beneficial owners is c/o the Company, 1215 W. Lakeview Court,
Romeoville, Illinois 60446.
|
|
(2)
|
Address is Rooms 803-4, 8F, Hang Seng Bank Building, 200 Hennessy
Road, Wanchai, Hong Kong. Holding information is based
on Amendment No. 7 to Schedule 13D filed by Sapinda Asia Limited on
November 4, 2015.
|
|
(3)
|
Secure I is a compartment of Safety Invest S.A.
(“
Safety
”), a company established under the
Luxembourg Securitization Law and incorporated as a
“société anonyme” under the laws of the Grand
Duchy of Luxembourg whose principal business is to enter into one
or more securitization transactions. Holding information is based
on the Schedule 13D filed by Safety on February 21,
2014.
|
|
(4)
|
Holdings consist of 13,195
shares
of common stock owned of record and 338,237
shares of common
stock issuable upon exercise of stock purchase warrants,
exercisable within 60 days of January 7, 2017.
|
|
(5)
|
Holdings include 19,264 shares of common stock owned of record
and 91,025 shares of common stock issuable upon exercise of stock
purchase warrants, exercisable within 60 days of January 7,
2017.
|
|
(6)
|
Holdings includes 2,381 shares of common stock owned of record
and 30,323 shares of common stock issuable upon exercise of stock
purchase warrants, exercisable within 60 days of January 7,
2017.
|
|
(7)
|
Holdings includes 61,899 shares of common stock owned of
record and 44,224 shares of common stock issuable upon exercise of
stock purchase warrants, exercisable within 60 days of January 7,
2017.
|
|
(8)
|
Holdings consist of 15,073 shares of common stock issuable upon
exercise of stock purchase warrants, exercisable within 60 days of
January 7, 2017.
|
|
(9)
|
Holdings consist of 15,073 shares of common stock issuable upon
exercise of stock purchase warrants, exercisable within 60 days of
January 7, 2017.
|
|
|
Sept. 30,
2016
|
Sept. 30,
2015
|
|
Beginning
balance
|
$
3,501,410
|
$
3,000,000
|
|
Stock
payable resulting from the acquisition of Track Group
Analytics
|
-
|
1,170,000
|
|
Payment
of shares for achieving performance milestones
|
(211,531
)
|
(668,590
)
|
|
Ending
balance
|
$
3,289,879
|
$
3,501,410
|
|
|
Sept. 30,
2016
|
Sept. 30,
2015
|
|
|
|
|
|
Related
party loan with an interest rate of 3% and 8% per annum for undrawn
and borrowed funds, respectively. Principal and interest due
September 30, 2017.
|
$
3,399,644
|
-
|
|
Total
related-party debt obligations
|
$
3,399,644
|
-
|
|
|
|
|
|
|
|
By Order of the Board of Directors,
|
|
January 10,
2017
|
|
/s/ Guy Dubois
|
|
|
|
Guy
Dubois
|
|
|
|
Chief Executive Officer and Chairman of the Board of
Directors
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|